SIRT3 and cancer: Tumor promoter or suppressor?

被引：157
作者：
Alhazzazi, Turki Y. [1 ]
Kamarajan, Pachiyappan [1 ]
Verdin, Eric [2 ]
Kapila, Yvonne L. [1 ]
机构：
[1] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA
[2] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2011年 / 1816卷 / 01期
关键词：
Sirtuin-3; SIRT3; Cancer; Tumor promoter; Tumor suppressor; HISTONE DEACETYLASE INHIBITORS; IN-SITU HYBRIDIZATION; BCL-2 FAMILY PROTEINS; FATTY-ACID OXIDATION; CARCINOMA CELL-LINES; CALORIE RESTRICTION; SIRT3-MEDIATED DEACETYLATION; CHROMOSOMAL ORGANIZATION; INSULIN-SECRETION; DOWN-REGULATION;
D O I：
10.1016/j.bbcan.2011.04.004
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Sirtuins (SIRT1-7), the mammalian homologues of the Sir2 gene in yeast, have emerging roles in age-related diseases, such as cardiac hypertrophy, diabetes, obesity, and cancer. However, the role of several sirtuin family members, including SIRT1 and SIRT3, in cancer has been controversial. The aim of this review is to explore and discuss the seemingly dichotomous role of SIRT3 in cancer biology with particular emphasis on its potential role as a tumor promoter and tumor suppressor. This review will also discuss the potential role of SIRT3 as a novel therapeutic target to treat cancer. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码：80 / 88
页数：9
相关论文
共 50 条
  • [1] SIRT3: Oncogene and Tumor Suppressor in Cancer
    Torrens-Mas, Margalida
    Oliver, Jordi
    Roca, Pilar
    Sastre-Serra, Jorge
    CANCERS, 2017, 9 (07): : 1 - 10
  • [2] SIRT3 functions as a tumor suppressor in hepatocellular carcinoma
    Zeng, Xianchun
    Wang, Nanzhu
    Zhai, Hui
    Wang, Rongpin
    Wu, Jiahong
    Pu, Wei
    TUMOR BIOLOGY, 2017, 39 (03) : 1 - 8
  • [3] Sirt3 is a tumor suppressor in lung adenocarcinoma cells
    Xiao, Kui
    Jiang, Jiehan
    Wang, Wei
    Cao, Shan
    Zhu, Liming
    Zeng, Huihui
    Ouyang, Ruoyun
    Zhou, Rui
    Chen, Ping
    ONCOLOGY REPORTS, 2013, 30 (03) : 1323 - 1328
  • [4] SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
    Deng, Chu-Xia
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2009, 5 (02): : 147 - 152
  • [5] Luciferase-Based Reporter to Monitor the Transcriptional Activity of the SIRT3 Promoter
    Satterstrom, F. Kyle
    Haigis, Marcia C.
    CELL-WIDE METABOLIC ALTERATIONS ASSOCIATED WITH MALIGNANCY, 2014, 543 : 141 - 163
  • [6] The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications
    Ouyang, Shumin
    Zhang, Qiyi
    Lou, Linlin
    Zhu, Kai
    Li, Zeyu
    Liu, Peiqing
    Zhang, Xiaolei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] SIRT3 upregulates the tumor suppressor miR-30c-2 in non-small cell lung cancer
    Liao, Hongtao
    Wu, Guanhuai
    Liu, Chaowu
    Yu, Ze
    Yang, Guocai
    ASIAN JOURNAL OF SURGERY, 2023, 46 (12) : 5855 - 5857
  • [8] Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease
    Ansari, Aneesa
    Rahman, Md. Shahedur
    Saha, Subbroto K.
    Saikot, Forhad K.
    Deep, Akash
    Kim, Ki-Hyun
    AGING CELL, 2017, 16 (01) : 4 - 16
  • [9] SIRT3: As Simple As It Seems?
    Lombard, David B.
    Zwaans, Bernadette M. M.
    GERONTOLOGY, 2014, 60 (01) : 56 - 64
  • [10] Potential relationship between Sirt3 and autophagy in ovarian cancer
    Shi, Yuchuan
    He, Runhua
    Yang, Yu
    He, Yu
    Zhan, Lei
    Wei, Bing
    ONCOLOGY LETTERS, 2020, 20 (05)
12345